Related Experiment Video
Updated: Nov 4, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care
1Third-year fellow in infectious diseases at the University of Washington in Seattle.
Abstract:
Long-acting injectable antiretroviral therapy (LA-ART) is a powerful new addition to the treatments available for patients living with HIV, but broad acceptance and uptake could be compromised by what we know about patients' and clinicians' experiences with long-acting injectable antipsychotics (LAI-APs). Treatment of stigmatized conditions, such as psychiatric illness or HIV, using long-acting injection is ethically fraught with patients' fear of coercion and forced administration. Strategies that emphasize patient-centered, patient-directed care and that place limits on when LAI can be administered forcibly can help promote LA-ART's acceptance and use.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Psychosis: Goals of Pharmacotherapy
Retrovirus Life Cycles
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Psychosis and Antipsychotic Drugs: Overview

